Skip to content
N

Nutraplus India

524764 BSE
Price unavailable
View as Markdown
MCP

No trades in 1Y

Key Insights

No strengths listed

Weaknesses

1
  • Company has low interest coverage ratio.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1243
OscillatorsBullish243
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
31.16
Neutral
MACD (12,26,9)
−0.36
Bullish
SMA (50)
3.37
Bearish
SMA (200)
5.06
Bearish

As of , the latest day with price data, so these readings are not current.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y−100.00%
5Y−100.00%
3YNegative, narrowed by ₹0.06 Cr
1YZero base
TTMZero base

Net profit

Net profit growth by window
10YTurned to loss
5YLoss narrowed by ₹24.18 Cr
3YLoss widened by ₹0.18 Cr
1YLoss widened by ₹0.29 Cr
TTMLoss widened by ₹0.27 Cr

Operating cash flow

Operating cash flow growth by window
10YOutflow narrowed by ₹9.22 Cr
5YOutflow narrowed by ₹13.86 Cr
3YTurned negative
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5YTiny sales
3YNo sales
1YNo sales
TTMNo sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹91.05 Cr
Mar 2018₹109 Cr
Mar 2019₹140 Cr
Mar 2020₹107 Cr
Mar 2021₹0.02 Cr
Mar 2022₹0.10 Cr
Mar 2023−₹0.06 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹6.26 Cr
Mar 2018₹0.14 Cr
Mar 2019₹2.19 Cr
Mar 2020−₹47.83 Cr
Mar 2021−₹24.52 Cr
Mar 2022−₹3.03 Cr
Mar 2023−₹0.16 Cr
Mar 2024−₹0.06 Cr
Mar 2025−₹0.05 Cr
Mar 2026−₹0.34 Cr

Quarterly Results

₹ Cr
524764 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.01
0.01
0.03
0.02
0
0
0.02
0.03
0.01
0.46
0.02
0.02
0.01
Operating Profit
−0.01
−0.01
−0.03
−0.02
0
0
−0.02
−0.03
−0.01
−0.46
−0.02
−0.02
−0.01
Other Income
0
0
0
0
0
0
0
0
0
0.1
0
0.06
0.03
Interest
0
0
0
0
0
0
0
−0.01
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
−0.01
−0.01
−0.03
−0.02
0
0
−0.02
−0.02
−0.01
−0.36
−0.02
0.04
0.02
Tax %
0%
0%
0%
0%
—
—
0%
0%
0%
0%
0%
0%
0%
Net Profit
−0.01
−0.01
−0.03
−0.02
0
0
−0.02
−0.02
−0.01
−0.36
−0.02
0.04
0.02
EPS (₹)
0
0
−0.01
−0.01
0
0
−0.01
−0.01
0
−0.11
−0.01
0.01
0.01

Profit & Loss

₹ Cr
524764 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
65
77.51
91.05
109
140
107
0.02
0.1
−0.06
0
0
0
0
Expenses
61.79
65.37
92.78
99.83
127
142
0.38
3.75
0.07
0.06
0.05
0.5
0.51
Operating Profit
3.21
12.14
−1.73
9.31
12.66
−35.77
−0.36
−3.65
−0.13
−0.06
−0.05
−0.5
−0.51
OPM %
4.94%
15.66%
−1.9%
8.53%
9.07%
−33.53%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
—
—
—
—
—
Other Income
−2.94
1.48
0.99
0.12
1.58
0.08
−23.36
0.62
0
0
0
0.16
0.19
Interest
4.52
4.86
5.01
4.67
6.85
7.43
0.8
0
0.03
0
0
0
0
Depreciation
1.4
1.72
2.21
3.88
4.03
4.7
0
0
0
0
0
0
0
PBT
−5.65
7.04
−7.96
0.88
3.36
−47.82
−24.52
−3.03
−0.16
−0.06
−0.05
−0.34
−0.32
Tax %
−28.14%
−12.64%
−21.36%
84.09%
34.82%
0%
0%
0%
0%
0%
0%
0%
—
Net Profit
−4.06
7.93
−6.26
0.14
2.19
−47.83
−24.52
−3.03
−0.16
−0.06
−0.05
−0.34
−0.32
EPS (₹)
−1.66
2.85
−1.84
0.04
0.64
−14.03
−7.19
−0.89
−0.05
−0.02
−0.01
−0.1
−0.1
Div. Payout %
0%
7.99%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
524764 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
11.16
12.67
17.05
17.05
17.05
17.05
17.05
17.05
17.05
17.05
17.05
17.05
Reserves
36.01
50.22
50.17
50.19
52.4
4.57
−19.1
−22.13
−22.28
−22.35
−22.4
−22.74
Borrowings
40.29
72.05
65.77
73.38
74.93
75.88
1.75
1.75
1.76
1.78
1.79
2.17
Other Liabilities
26.6
30.66
37.27
31.21
25.32
39.37
34.99
12.28
8.72
8.77
8.73
8.67
Total Liabilities
114
166
170
172
170
137
34.69
8.95
5.25
5.25
5.17
5.15
Fixed Assets
22.95
32.89
38.64
72.31
82.44
81.19
0
0
0
0
0
0
CWIP
13.42
37.53
48.27
21.59
17.26
12.67
0.12
0
0
0
0
0
Investments
4.2
4.15
4.16
4.15
4.15
0.15
0.15
0.15
0.15
0.15
0.15
0.15
Other Assets
73.49
91.03
79.19
73.78
65.85
42.86
34.42
8.8
5.1
5.1
5.02
5
Total Assets
114
166
170
172
170
137
34.69
8.95
5.25
5.25
5.17
5.15

Cash Flow

₹ Cr
524764 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−16.49
−9.61
19.66
6.69
12.36
9.07
−14.25
−0.15
0.02
−0.01
0
−0.39
Investing
−5.1
−34.42
−18.59
−10.7
−9.74
−2.69
93.77
0.12
0
0
0
0
Financing
31.53
35.54
−1.91
4
−2.66
−7.57
−80.25
0
−0.03
0.02
0
0.39
Net Cash Flow
9.94
−8.48
−0.84
−0.01
−0.03
−1.18
−0.73
−0.03
−0.01
0.01
0
−0.01
Free Cash Flow
−37.12
−45.37
0.96
−4.13
2.5
6.24
79.49
−0.03
0.02
−0.01
0
−0.39
CFO/OP
−514
−72
−1,139
80
103
−26
3,958
4
−15
17
0
78

Ratios

524764 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
75.13
120
105
83.71
42.97
9.48
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
1,898
—
—
—
—
Inventory Days
134
181
113
111
124
89.78
—
364
—
—
—
—
Days Payable
186
190
177
133
75.89
35.11
—
879
—
—
—
—
Cash Conversion Cycle
23.09
111
40.6
61.73
91.1
64.15
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
1,383
—
—
—
—
Working Capital Days
60.53
117
20.61
28.43
1.99
−161
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
0
—
—
—
—
ROCE %
2.89%
9.65%
−2.85%
4.06%
8.78%
−33.35%
−0.56%
—
—
—
—
—

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Nutraplus insights

62 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Jun 2026

  • Public 59.72%
  • Promoters 40.07%
  • DIIs 0.21%

Pledge data not available

Change vs previous quarter

Documents

  • Concall · Sep 2016
    PPT

Frequently Asked Questions about Nutraplus India

What does Nutraplus India Ltd do?
Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.
Where is Nutraplus India Ltd (NUTRA) listed?
Nutraplus India Ltd trades under code 524764 on the BSE.
Which sector does Nutraplus India Ltd belong to?
Nutraplus India Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.

Company Information

Nutraplus India is engaged in the Business of Drugs and Pharmaceuticals.

Face Value ₹5

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524764.md for Nutraplus India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More